9 research outputs found

    Demographic and clinical characteristics of 96 patients randomized to treatment of Azithromycin (nβ€Š=β€Š50) or placebo (nβ€Š=β€Š46) and by ethnicity.

    No full text
    <p><b>Median and IQR (25–75) for continuous variables. Actual numbers for categorical variables and percentages.</b></p><p><b>NB</b>: Missing variables described.</p><p><b>Azithromycin</b>: Gestational age β€Š=β€Š3 (6%). Birth weight β€Š=β€Š6 (12%). Mother smoked during pregnancy β€Š=β€Š3 (6%). Exposure to household smoke β€Š=β€Š2 (4%), <b>Placebo</b>: Gestational age: β€Š=β€Š2 (4%). Birth weight β€Š=β€Š3 (6.5%).</p><p><b>Indigenous children</b>: Gestational age β€Š=β€Š2 (3.3%). Birth weight β€Š=β€Š4 (6.5%). Mother smoked during pregnancy β€Š=β€Š2 (3%). Exposure to household smoke β€Š=β€Š1 (1.6%): <b>Non Indigenous children</b>: Gestational age: β€Š=β€Š3 (8.6%). Birth weight β€Š=β€Š5 (14.3%) Mother smoked during pregnancy β€Š=β€Š1 (3%). Exposure to household smoke β€Š=β€Š1 (3%).</p